NCT06211166View on ClinicalTrials.gov

Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Acute LeukemiaMDSMDS/MPNCML
Interventions
DIAGNOSTIC_TEST

Digital PCR

digital Polymerase Chain Reaction (dPCR)

DIAGNOSTIC_TEST

Quantitative PCR

Real-time Polymerase Chain Reaction (real-time PCR)

DIAGNOSTIC_TEST

MFC

Multicolor Flow Cytometry

Trial Locations (1)

100044

RECRUITING

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER